Position in DNLI
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$283,434
+$53,591 QoQ
Shares Held
11,020
-7.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#186
of 290 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. DNLI ranks #56 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in DNLI
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,434 | 11,020 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $229,843 | 11,971 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $194,108 | 11,757 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $309,595 | 21,322 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $315,236 | 22,533 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $320,882 | 23,603 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $532,692 | 26,138 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,087,335 | 37,327 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $880,363 | 37,914 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $804,794 | 39,220 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $850,524 | 39,633 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,120,869 | 54,332 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,608,796 | 54,517 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,191,260 | 51,704 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $617,632 | 22,209 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $577,677 | 18,823 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||